Drug combination for stage IV melanoma shows success in trial

by CU Anschutz Medical CampusMelanoma. Credit: Wikimedia Commons/National Cancer InstituteA new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year cli

Oncology February 23,2024

Drug combination for stage IV melanoma shows success in trial

by CU Anschutz Medical CampusMelanoma. Credit: Wikimedia Commons/National Cancer InstituteA new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year cli

Oncology February 23,2024

It's all about quality: Effect of dietary fat composition on liver angiogenesis and lymphangiogenesis

by Shinshu UniversityIn a new study, scientists from Japan demonstrate that saturated/trans fats in the diet, and not cholesterol, promote hepatic angiogenesis and lymphangiogenesis and thereby trigge

Oncology February 23,2024

It's all about quality: Effect of dietary fat composition on liver angiogenesis and lymphangiogenesis

by Shinshu UniversityIn a new study, scientists from Japan demonstrate that saturated/trans fats in the diet, and not cholesterol, promote hepatic angiogenesis and lymphangiogenesis and thereby trigge

Oncology February 23,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Oncology February 23,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Oncology February 23,2024

Targeting refractory prostate cancer: A novel radiopharmaceutical hits the bullseye

by Osaka UniversityTargeted alpha therapy using an astatine-labeled PSMA ligand ([At-211]PSMA5). Credit: Tadashi Watabe (Osaka University)As the saying goes, when all you have is a hammer, everyt

Oncology February 23,2024

Targeting refractory prostate cancer: A novel radiopharmaceutical hits the bullseye

by Osaka UniversityTargeted alpha therapy using an astatine-labeled PSMA ligand ([At-211]PSMA5). Credit: Tadashi Watabe (Osaka University)As the saying goes, when all you have is a hammer, everyt

Oncology February 23,2024

Study identifies novel epigenetic changes in pediatric brain cancer

by Melissa Rohman,Northwestern UniversityDNA methylation and transcriptomic landscape of recurrent ependymoma tumors. A Time-course summary of surgery, radio- and chemotherapy treatment and tumo

Oncology February 23,2024

Study identifies novel epigenetic changes in pediatric brain cancer

by Melissa Rohman,Northwestern UniversityDNA methylation and transcriptomic landscape of recurrent ependymoma tumors. A Time-course summary of surgery, radio- and chemotherapy treatment and tumo

Oncology February 23,2024

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Oncology February 23,2024

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Oncology February 23,2024

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is

Oncology February 23,2024

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is

Oncology February 23,2024

Researchers uncover novel gene that regulates leukemia development and progression

by Pusan National UniversityResearchers from Pusan National University find that suppressing the expression of SURF4 reduces pathologic processes that contribute to leukemia progression. Credit: Profe

Oncology February 23,2024

Researchers uncover novel gene that regulates leukemia development and progression

by Pusan National UniversityResearchers from Pusan National University find that suppressing the expression of SURF4 reduces pathologic processes that contribute to leukemia progression. Credit: Profe

Oncology February 23,2024

Researchers expanding the types of cancer CAR-T therapy can target

by Gregory Allen,The ConversationKiller T cells (green and red), or cytotoxic T cells, surround a cancer cell (blue, center). Credit:NICHD/J. Lippincott-Schwartz,CC BY-NC-NDTeaching

Oncology February 23,2024

Researchers expanding the types of cancer CAR-T therapy can target

by Gregory Allen,The ConversationKiller T cells (green and red), or cytotoxic T cells, surround a cancer cell (blue, center). Credit:NICHD/J. Lippincott-Schwartz,CC BY-NC-NDTeaching

Oncology February 23,2024

Study uncovers role of ultraviolet radiation in development of rare leukemia in the skin

by Dana-Farber Cancer InstituteSkin tumor (top) from a representative patient with BPDCN showing infiltration by malignant cells (haematoxylin and eosin (H&E), left) expressing the pDC marker

Oncology February 23,2024

Study uncovers role of ultraviolet radiation in development of rare leukemia in the skin

by Dana-Farber Cancer InstituteSkin tumor (top) from a representative patient with BPDCN showing infiltration by malignant cells (haematoxylin and eosin (H&E), left) expressing the pDC marker

Oncology February 23,2024